AVITA Medical, Inc. (RCEL) Finished Goods (2018 - 2022)

AVITA Medical (RCEL) has reported Finished Goods for 5 consecutive years, with $610000.0 the latest figure, recorded in Q4 2022.

• For the quarter ending Q4 2022, Finished Goods fell 16.89% year-over-year to $610000.0; the trailing twelve-month figure through Dec 2022 stood at $610000.0 (down 16.89% YoY), and the FY2022 full-year result was $610000.0, down 16.89% from the prior year.
• Finished Goods eased to $610000.0 in Q4 2022 per RCEL's latest filing, from $734000.0 in the prior quarter.
• Across five years, Finished Goods topped out at $734000.0 in Q4 2021 and bottomed at $132212.7 in Q2 2019.
• Historically, Finished Goods has averaged $393920.7 across 5 years, with a median of $354655.7 in 2018.
• The sharpest annual moves came in 2019 and 2021: Finished Goods plunged 53.66% in 2019, then surged 138.2% in 2021.
• Over 5 years, Finished Goods stood at $285311.3 in 2018, then sank by 53.66% to $132212.7 in 2019, then jumped by 34.63% to $178000.0 in 2020, then surged by 312.36% to $734000.0 in 2021, then declined by 16.89% to $610000.0 in 2022.
• According to Business Quant data, Finished Goods over the past three periods registered $610000.0, $734000.0, and $424000.0 for Q4 2022, Q4 2021, and Q2 2021 respectively.